Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Finding and Managing Needles in Haystacks: Inborn Errors of Immunity
Description
The presentation discusses the importance of recognizing inborn errors of immunity in patients with skin conditions like atopic dermatitis and warts, which can lead to serious infections, autoimmune diseases, or malignancies. It emphasizes that while genetic testing and newborn screenings are essential, many conditions go undiagnosed since there are over 400 inborn errors of immunity, and clinical diagnosis becomes crucial. Dermatologists play a vital role in identifying these patients, especially when skin manifestations are not typical. The presentation outlines specific clinical signs and symptoms that should raise red flags, including recurrent infections, unusual autoimmunity at a young age, and severe dermatitis resistant to treatment. It describes several case studies, such as patients with Wiskott-Aldrich syndrome and their treatment options, highlighting the benefits of early identification for interventions like stem cell transplants or gene therapy. The talk also addresses wart outliers linked to immune deficiencies, urging practitioners to consider broader immune status when treating persistent or resistant warts. The overall message is to thoroughly evaluate dermatological patients for potential underlying immune disorders to improve outcomes.
View moreConclusions
- Skin manifestations are a common initial sign of inborn errors of immunity, often leading to delayed diagnosis if not recognized early.
- Atopic dermatitis and warts should prompt further investigation for potential inborn errors of immunity when associated with recurrent infections or unusual clinical features.
- Patients with Wiskott-Aldrich syndrome exhibit a classic triad of eczema, thrombocytopenia, and recurrent infections, which can lead to serious complications if not diagnosed promptly.
- Early identification and management of inborn errors of immunity can significantly improve outcomes, including survival rates for those requiring stem cell transplant.
- Dupilumab shows promise as an effective treatment option for skin manifestations in selected patients with inborn errors of immunity, such as Wiskott-Aldrich syndrome.
- Patients with refractory warts may indicate underlying immunodeficiency and should be evaluated for associated infections and systemic issues.
- There are specific clinical clues and guidelines for identifying patients at risk for inborn errors of immunity, especially in cases of atopic dermatitis and dermatological conditions.
- doi: 10.1111/j.1525-1470.2011.01409.x
- doi: 10.3389/fimmu.2021.751469
- doi: 10.3390/antib12040070
- doi:10.3389/fped.2019.00451
- doi: 10.1182/blood.2021014687
- doi: 10.3760/cma.j.cn112140-20220810-00720
- doi: 10.1182/blood.2022019117
- doi:10.3389/fped.2023.1129249
- doi:10.1016/j.jaip.2021.08.042
- doi: 10.15264/cpho.2022.29.1.12
- doi: 10.1111/j.1365-2249.2007.03432.x
- doi: 10.1016/j.jaip.2023.04.018
- doi: 10.1016/j.waojou.2021.100513
- doi: 10.1016/j.jaip.2019.01.045
- doi: 10.1002/iid3.833
- doi: 10.1016/j.jaip.2019.03.001
- doi: 10.1182/blood-2017-02-708552
- doi: 10.1172/JCI164918
- doi: 10.1111/pde.15414